Selectquote, Inc. is a US-listed company in the insurance brokers industry. Its financial year ends in June.
Loading chart…
Third-party market data · may be delayed
~$0.5
Price-to-book vs peers
Base case. Range ~$0.5–$8.9. Book value per share times peers' typical (harmonic-mean) price-to-book.
No Buy/Hold/Sell rating is issued: only 1 valuation models apply; a rating needs 3.
Selectquote, Inc. valuation: adjust assumptions and compare models →
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
Revenue for the twelve months to June 2026 was $1.62bn, up 6.0% on a year earlier, slower than the 10.3% growth a quarter earlier. The diluted share count is up 3.5% on a year earlier, which dilutes existing holders. Our price-to-earnings vs peers value is $1.32 a share, against a share price of $0.33.
Source: 10-K filed August 25, 2026 on SEC EDGAR · Financials · Valuation
Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.
Selectquote, Inc.'s trailing-twelve-month revenue grew 6.0% year on year, with a free-cash-flow margin of 1.7%.
Current signal Revenue growth decelerating: TTM revenue growth slowed to 6.0% (-4.3pp vs the prior quarter), the 9th consecutive quarterly slowdown.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Nothing in Selectquote, Inc.'s latest figures clears our strength thresholds.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
We value Selectquote, Inc. as an asset manager, broker or exchange, with every model that fits that kind of business. Cost of equity 9.4%: the 10-year Treasury yield (4.9%) plus a beta of 1 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. | — | Does not apply: no positive earnings in the latest twelve months |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | — | Does not apply: the model gives no positive value |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | — | Does not apply: return on equity is not positive |
| Price-to-book vs peers Book value per share times peers' typical (harmonic-mean) price-to-book. | ~$0.5 ~$2.2–$8.9 | Included |
| Dividend discount (two-stage) Dividends for five years at the growth the business can fund, then a steady payout and growth. | — | Does not apply: pays no regular dividend |
| Combined value Weighted average of the models that apply: the primary model (price-to-earnings vs peers) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. | ~$0.5 ~$0.5–$8.9 | 1 model |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Selectquote, Inc. with insurance brokers in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
Weak moat
How hard Selectquote's competitive advantage looks for rivals to wear away, judged from 8 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
Cash operating profit has been a median 57.4% of total assets over 5 years.
Operating margin has been a median 4.7%; its worst year was -45.3%.
The diluted share count rose 13.7% over five years; stock-based pay has been a median 1.0% of revenue.
AI disruption exposure: High. In this industry, the core product is information work that AI systems increasingly perform. The score above includes a 15-point deduction for that exposure (54 before it).
Next results: November 4, 2026, before the open. Analysts expect revenue of $278m and EPS of −$0.26 (range −$0.26 to −$0.26) for the quarter.
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | −$0.04 | −150% | $1.4bn | −14% |
| Next | $0.02 | +150% | $1.5bn | +5% |
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | −$0.14 | −$0.17 | −25.9% |
| Mar 2026 | $0.02 | $0.04 | +115.0% |
| Dec 2025 | $0.28 | $0.29 | +2.2% |
| Sept 2025 | −$0.32 | −$0.24 | +25.5% |
Adjusted EPS as companies report it, against the average analyst estimate.
Last 12 months −80.7%
| Part | Then | Now | Effect |
|---|---|---|---|
| Revenue (last 12 months) | $1.5bn | $1.6bn | +6.0% |
| Net margin | 3.1% | 3.8% | +23.3% |
| P/E multiple | 8.0x | 1.2x | −84.7% |
| Share count | 182m | 188m | −3.3% |
Biggest factor: p/e multiple.
Last 3 years −69.5%
| Part | Then | Now | Effect |
|---|---|---|---|
| Revenue (last 12 months) | $1.0bn | $1.6bn | +61.4% |
| P/S multiple | 0.2x | 0.0x | −78.6% |
| Share count | 166m | 188m | −11.7% |
Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.
| Calendar year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 to date |
|---|---|---|---|---|---|---|
| Return | ||||||
| SLQT | −56% | −93% | +104% | +172% | −62% | −72% |
| Industry peers (median) | +14% | −21% | +16% | +25% | −19% | −1% |
| S&P 500 | +29% | −18% | +26% | +25% | +18% | +11% |
| Months that ended higher | ||||||
| SLQT | 50% | 17% | 50% | 50% | 42% | 36% |
| S&P 500 | 75% | 42% | 67% | 75% | 75% | 46% |
| Largest fall from a high during the year | ||||||
| SLQT | −76% | −94% | −65% | −58% | −78% | −82% |
| S&P 500 | −5% | −25% | −10% | −8% | −19% | −9% |
Worst fall since May 21, 2020: 99% from April 6, 2021 to October 20, 2026. Getting back needed a 10518% gain, and the shares have not yet recovered.
| Results released | Next day | S&P 500 next day | 5 days | 21 days |
|---|---|---|---|---|
| August 25, 2026 | −29.1% | +0.3% | −30.9% | −47.2% |
| May 5, 2026 | +47.4% | +2.2% | +24.1% | +22.5% |
| February 5, 2026 | −24.1% | +0.6% | −41.9% | −47.7% |
| November 6, 2025 | −18.8% | −1.0% | −26.8% | −36.6% |
| August 21, 2025 | +47.0% | +1.1% | +23.5% | +12.0% |
| May 12, 2025 | −10.1% | +4.0% | −15.4% | −15.4% |
| February 10, 2025 | +30.8% | +0.8% | +38.1% | −17.4% |
| November 4, 2024 | +6.9% | +1.0% | +20.1% | +46.1% |
| September 13, 2024 | −49.0% | +0.7% | −44.8% | −39.3% |
| May 9, 2024 | +4.8% | +0.7% | +22.0% | +13.2% |
| February 7, 2024 | +6.3% | +0.9% | +53.2% | +64.0% |
| November 2, 2023 | −4.3% | +2.8% | −11.6% | −2.9% |
Source: SEC EDGAR filings. Retrieved October 26, 2026.
| Period | Revenue (TTM) |
|---|---|
| FY24 Q1 | $1.1B |
| FY24 Q2 | $1.2B |
| FY24 Q3 | $1.2B |
| FY24 Q4 | $1.3B |
| FY25 Q1 | $1.4B |
| FY25 Q2 | $1.5B |
| FY25 Q3 | $1.5B |
| FY25 Q4 | $1.5B |
| FY26 Q1 | $1.6B |
| FY26 Q2 | $1.6B |
| FY26 Q3 | $1.6B |
| FY26 Q4 | $1.6B |
Source: SEC EDGAR filings. Retrieved October 26, 2026.
| Period | Revenue growth, TTM YoY |
|---|---|
| FY24 Q1 | 39.3% |
| FY24 Q2 | 29.5% |
| FY24 Q3 | 34.3% |
| FY24 Q4 | 31.8% |
| FY25 Q1 | 28.7% |
| FY25 Q2 | 25.7% |
| FY25 Q3 | 20.4% |
| FY25 Q4 | 15.5% |
| FY26 Q1 | 13.2% |
| FY26 Q2 | 11.1% |
| FY26 Q3 | 10.3% |
| FY26 Q4 | 6.0% |
Source: SEC EDGAR filings. Retrieved October 26, 2026.
| Period | Operating margin (TTM) |
|---|---|
| FY24 Q1 | 2.7% |
| FY24 Q2 | 2.7% |
| FY24 Q3 | 2.4% |
| FY24 Q4 | 4.9% |
| FY25 Q1 | 5.4% |
| FY25 Q2 | 6.2% |
| FY25 Q3 | 5.3% |
| FY25 Q4 | 4.5% |
| FY26 Q1 | 2.5% |
| FY26 Q2 | 2.7% |
| FY26 Q3 | 3.5% |
| FY26 Q4 | 4.6% |
Source: SEC EDGAR filings. Retrieved October 26, 2026.
| Period | FCF margin (TTM) |
|---|---|
| FY24 Q1 | 0.2% |
| FY24 Q2 | 0.3% |
| FY24 Q3 | -1.2% |
| FY24 Q4 | 0.9% |
| FY25 Q1 | 1.4% |
| FY25 Q2 | 1.2% |
| FY25 Q3 | 2.9% |
| FY25 Q4 | -0.9% |
| FY26 Q1 | -1.2% |
| FY26 Q2 | 0.5% |
| FY26 Q3 | -0.4% |
| FY26 Q4 | 1.7% |
| Fiscal year | 2018 Jun 2018 | 2019 Jun 2019 | 2020 Jun 2020 | 2021 Jun 2021 | 2022 Jun 2022 | 2023 Jun 2023 | 2024 Jun 2024 | 2025 Jun 2025 | 2026 Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| Revenue | 234 | 337 | 529 | 930 | 764 | 1,003 | 1,322 | 1,527 | 1,618 |
| Gross profit | 150 | 233 | 362 | 928 | 700 | 777 | 917 | 896 | 888 |
| EBITDA | 47 | 101 | 138 | 208 | −321 | 39 | 90 | 89 | 91 |
| Operating income | 43 | 96 | 130 | 192 | −346 | 12 | 65 | 68 | 74 |
| Net income | 35 | 73 | 79 | 125 | −298 | −59 | −34 | 48 | 62 |
| Diluted EPS | $0.23 | $0.55 | −$0.18 | $0.75 | −$1.81 | −$0.35 | −$0.20 | $0.01 | −$0.06 |
| Growth (year on year) | |||||||||
| Revenue | — | +44.4% | +56.9% | +75.7% | −17.8% | +31.3% | +31.8% | +15.5% | +6.0% |
| EBITDA | — | +116.6% | +36.8% | +50.8% | −254.2% | — | +126.9% | −0.7% | +2.8% |
| Operating income | — | +123.1% | +35.2% | +47.7% | −280.0% | — | — | +6.1% | +7.9% |
| Net income | — | +108.0% | +9.5% | +57.1% | −338.3% | — | — | — | +30.7% |
| Diluted EPS | — | +139.1% | −132.7% | — | −341.3% | — | — | — | −700.0% |
| Margins | |||||||||
| Gross margin | 64.3% | 69.1% | 68.4% | 99.8% | 91.6% | 77.5% | 69.4% | 58.7% | 54.9% |
| EBITDA margin | 20.0% | 29.9% | 26.1% | 22.4% | −42.1% | 3.9% | 6.8% | 5.8% | 5.6% |
| Operating margin | 18.5% | 28.5% | 24.6% | 20.7% | −45.3% | 1.2% | 4.9% | 4.5% | 4.6% |
| Net margin | 14.9% | 21.5% | 15.0% | 13.4% | −38.9% | −5.8% | −2.6% | 3.1% | 3.8% |
| Free-cash-flow margin | −4.4% | −1.1% | −13.5% | −14.0% | −47.5% | −2.1% | 0.9% | −0.9% | 1.7% |
| Cash flow | |||||||||
| Cash from operations | −5 | 0 | −62 | −115 | −338 | −19 | 15 | −12 | 32 |
| Capital spending | 5 | 4 | 9 | 15 | 25 | 1 | 3 | 2 | 4 |
| Free cash flow | −10 | −4 | −71 | −130 | −363 | −21 | 12 | −14 | 28 |
| Stock-based pay | 0 | 0 | 9 | 5 | 7 | 11 | 14 | 18 | 15 |
| Free cash flow after stock pay | −10 | −4 | −81 | −136 | −370 | −32 | −2 | −32 | 13 |
| Balance sheet | |||||||||
| Cash | 1 | 1 | 321 | 286 | 141 | 83 | 43 | 32 | 16 |
| Total debt | 0 | 11 | 312 | 461 | 706 | 699 | 683 | 397 | 387 |
| Net debt (negative = net cash) | −1 | 10 | −9 | 175 | 565 | 615 | 641 | 365 | 371 |
| Diluted shares | 96m | 132m | 97m | 166m | 164m | 166m | 169m | 182m | 188m |
| Returned to shareholders | |||||||||
| Dividends | 2 | 2 | 275 | 0 | 0 | — | — | — | — |
| Buybacks | 0 | 0 | 0 | 0 | — | — | — | — | — |
| Total returned | 2 | 2 | 275 | 0 | 0 | — | — | — | — |
| Quarter | 2025 Q1 Sept 2024 | 2025 Q2 Dec 2024 | 2025 Q3 Mar 2025 | 2025 Q4 Jun 2025 | 2026 Q1 Sept 2025 | 2026 Q2 Dec 2025 | 2026 Q3 Mar 2026 | 2026 Q4 Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Income | ||||||||
| Revenue | 292 | 481 | 408 | 345 | 329 | 537 | 431 | 322 |
| Gross profit | 163 | 325 | 246 | 163 | 136 | 332 | 260 | 160 |
| EBITDA | −6 | 76 | 27 | −8 | −36 | 80 | 40 | 8 |
| Operating income | −12 | 71 | 22 | −13 | −41 | 75 | 36 | 3 |
| Net income | −45 | 53 | 26 | 13 | −30 | 69 | 40 | −17 |
| Diluted EPS | −$0.26 | $0.30 | $0.03 | −$0.12 | −$0.26 | $0.26 | $0.11 | −$0.17 |
| Growth (year on year) | ||||||||
| Revenue | +25.6% | +18.7% | +8.4% | +12.3% | +12.5% | +11.6% | +5.6% | −6.8% |
| EBITDA | — | +24.2% | −32.1% | — | — | +4.8% | +49.4% | — |
| Operating income | — | +28.3% | −33.3% | — | — | +6.2% | +62.9% | — |
| Net income | — | +174.5% | +204.3% | — | — | +30.2% | +54.5% | −230.9% |
| Diluted EPS | — | +172.7% | −40.0% | — | — | −13.3% | +266.7% | — |
| Margins | ||||||||
| Gross margin | 55.7% | 67.5% | 60.2% | 47.2% | 41.4% | 61.8% | 60.3% | 49.8% |
| EBITDA margin | −2.2% | 15.8% | 6.6% | −2.2% | −11.1% | 14.8% | 9.4% | 2.5% |
| Operating margin | −4.1% | 14.7% | 5.4% | −3.6% | −12.4% | 14.0% | 8.3% | 1.1% |
| Net margin | −15.2% | 11.1% | 6.4% | 3.7% | −9.3% | 12.9% | 9.3% | −5.2% |
| Free-cash-flow margin | −5.8% | −6.0% | 17.2% | −11.0% | −6.9% | −0.2% | 13.0% | −1.4% |
| Cash flow | ||||||||
| Cash from operations | −17 | −29 | 71 | −37 | −22 | 0 | 57 | −3 |
| Capital spending | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Free cash flow | −17 | −29 | 70 | −38 | −23 | −1 | 56 | −5 |
| Stock-based pay | 4 | 5 | 5 | 5 | 4 | 3 | 4 | 3 |
| Free cash flow after stock pay | −21 | −34 | 65 | −43 | −27 | −5 | 52 | −8 |
| Last 12 months unless stated | SLQT | BWIN | HGTY | CRD.A | RYAN | ERIE | Median |
|---|---|---|---|---|---|---|---|
| Revenue, last 12 months | $1.6bn | $1.7bn | $1.4bn | $1.3bn | $3.3bn | $4.1bn | $1.6bn |
| Revenue growth, last 12 months | 6.0% | 18.9% | 5.2% | −3.6% | 9.8% | 2.0% | 7.6% |
| Revenue growth, 3-year average | 17.3% | — | 17.1% | −1.0% | 18.0% | 9.4% | 13.8% |
| Revenue growth, latest quarter | −6.8% | 30.1% | −6.5% | −0.9% | 4.7% | 0.3% | 4.7% |
| Gross margin | 54.9% | — | — | 28.2% | — | — | 44.3% |
| Operating margin | 4.6% | −6.9% | 8.0% | — | 15.6% | 17.9% | 9.4% |
| Operating margin, 3-year average | 4.6% | 0.4% | 3.5% | — | 16.7% | 17.7% | 4.9% |
| Net margin | 3.8% | −4.7% | 4.9% | 2.0% | 3.2% | 14.0% | 4.9% |
| Cash from operations / revenue | 2.0% | 5.2% | 21.4% | 6.1% | 17.5% | 16.8% | 15.5% |
| Free-cash-flow margin | 1.7% | 2.5% | 19.4% | 5.5% | 17.5% | 13.4% | 13.4% |
| Free-cash-flow margin, 3-year average | 0.6% | −2.4% | 14.5% | 5.0% | 20.0% | 13.5% | 13.7% |
| Stock pay / revenue | 0.9% | 4.3% | 1.3% | 0.2% | 2.2% | — | 1.4% |
| Change in share count | 3.5% | 23.3% | — | 3.1% | — | — | 5.7% |
| Measure | Company | Peer median | Rank |
|---|---|---|---|
| Revenue growth Growth | 6.0% | 7.6% | 10 of 17 |
| Change in growth rate Growth | -4.3pp | -0.7pp | 13 of 17 |
| Operating margin Profitability | 4.6% | 10.8% | 9 of 14 |
| Net margin Profitability | 3.8% | 4.9% | 10 of 17 |
| Stock pay as % of revenue Cash generation | 0.9% | 1.5% | 5 of 16 |
| Change in share count Balance sheet | 3.5% | 7.4% | 5 of 12 |
Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Pharmacy | $831M | 51.3% | ▲ 14.0% |
| Services | $788M | 48.7% | ▼ 1.3% |
From Selectquote, Inc.'s 10-K filed August 25, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Abrams Bison Investments, LLC | $6.7M | 7.9M | 12.3% | 0.0% |
| Mariner, LLC | $5.5M | 6.6M | 10.2% | ▲ 1.0% |
| Vanguard Capital Management LLC | $5.1M | 6.1M | 9.5% | ▲ 2.0% |
| AQR Capital Management LLC | $2.1M | 2.5M | 3.8% | ▲ 114.2% |
| Captrust Financial Advisors | $2M | 2.4M | 3.7% | ▲ 2.9% |
| Blackrock, Inc. | $1.8M | 2.2M | 3.4% | ▼ 79.6% |
| Qube Research & Technologies Ltd | $1.8M | 2.1M | 3.4% | New |
| Jane Street Group, LLC | $1.8M | 2.1M | 3.3% | New |
| Diametric Capital, LP | $1.7M | 2.0M | 3.1% | ▲ 0.9% |
| Geode Capital Management, LLC | $1.5M | 1.7M | 2.7% | ▼ 49.9% |
| Millennium Management LLC | $1.4M | 1.6M | 2.6% | New |
| Gsa Capital Partners LLP | $1.1M | 1.3M | 2.1% | ▲ 159.3% |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Selectquote, Inc.'s complete shareholder register. Values are as reported by the filers .
| Insider | Date | Trade | Shares | Price | Value |
|---|---|---|---|---|---|
| Devine Denise L Director | May 19, 2026 | Sell pre-set plan | 4,000 | $1.02 | $4,080 |
| Grant Robert Clay PRESIDENT | February 11, 2026 | Buy | 39,366 | $0.89 | $35,036 |
| Grant Robert Clay PRESIDENT | February 11, 2026 | Buy | 39,514 | $0.89 | $35,167 |
| Grant Robert Clay PRESIDENT | February 11, 2026 | Buy | 40,021 | $0.88 | $35,218 |
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
Next expected around November 5, 2026 estimated from the company's past filing pattern, not announced
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| Financial statements | SEC 10-K and 10-Q filings | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
